2.40
price down icon1.23%   -0.03
after-market 시간 외 거래: 2.41 0.01 +0.42%
loading

Aerovate Therapeutics Inc (AVTE) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
11.57%
24.62
22.07 21.37 20.34 17.64
Operating Income/Loss
11.57%
-24.62
-22.07 -21.37 -20.34 -17.64
Income/Loss From Continuing Operations Before Tax
13.90%
-23.19
-20.36 -19.56 -19.02 -16.52
Income/Loss From Continuing Operations After Tax
13.58%
-23.19
-20.41 -19.56 -19.02 -16.52
Net Income/Loss
13.58%
-23.19
-20.41 -19.56 -19.02 -16.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,949%
27.80
0.4595 27.64 25.17 24.78
Diluted Average Shares
5,949%
27.80
0.4595 27.64 25.17 24.78
Basic Earnings Per Share
12.16%
-0.83
-0.74 -0.71 -0.76 -0.67
Diluted Earnings Per Share
12.16%
-0.83
-0.74 -0.71 -0.76 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
자본화:     |  볼륨(24시간):